{"id":1026,"date":"2018-11-27T07:46:06","date_gmt":"2018-11-27T07:46:06","guid":{"rendered":"https:\/\/www.sathguru.com\/news\/?p=1026"},"modified":"2021-04-01T11:43:35","modified_gmt":"2021-04-01T11:43:35","slug":"sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave","status":"publish","type":"post","link":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/","title":{"rendered":"Sathguru\u2019s Healthcare Practice Lead moderates Biosimilars Panel at CII Biotech Conclave"},"content":{"rendered":"

[vc_row][vc_column][vc_wp_text]Sathguru\u2019s Healthcare Practice Lead Pushpa Vijayaraghavan moderated the panel on \u201cCurrent state of biosimilars and prospects for the future\u201d at the CII National Biotech Conclave 2018 held in New Delhi on the 22nd of November.<\/p>\n

The session discussed current landscape of the biosimilars segment, regulatory considerations given the 2016 guidelines in India and global regulatory precedents and roadmap for Indian industry to achieve global leadership in regulated and RoW markets. The panel touched upon critical aspects such as need to strengthen upstream technology backbone, fostering market maturity, partnering to manage risk and pool strengths and global developments such as the WHO PQ pilot that is likely to impact RoW market development.<\/p>\n

The cross-sectional panel included special address by Dr SR Rao, Senior Adviser Department of Biotechnology, Dr Anil Koul, Director of CSIR IMTECH, Mr Sunil Thakur Managing Director at Quadria Capital, a healthcare focused PE fund, Dr Jaspreet Singh Intas Pharmaceuticals and Mr Atin Tomar, CEO of CPL Biologicals.<\/p>\n

The CII-Sathguru position paper on \u201cIndian Biosimilars Industry: Roadmap to Actualize Global Leadership\u201d<\/strong> was also released at the event. The position paper can be downloaded at – Indian Biosimilars Industry<\/a>[\/vc_wp_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_gallery interval=”3″ images=”1030,1035,1031″ img_size=”large”][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_wp_text]Sathguru\u2019s Healthcare Practice Lead Pushpa Vijayaraghavan moderated the panel on \u201cCurrent state of biosimilars and prospects for the future\u201d at the CII National Biotech Conclave 2018 held in New Delhi on the 22nd of November. The session discussed current landscape of the biosimilars segment, regulatory considerations given the 2016 guidelines in India and global regulatory […]<\/p>\n","protected":false},"author":1,"featured_media":1031,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,4],"tags":[],"class_list":["post-1026","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured-news","category-healthcare"],"yoast_head":"\nSathguru\u2019s Healthcare Practice Lead moderates Biosimilars Panel at CII Biotech Conclave<\/title>\n<meta name=\"description\" content=\"The session discussed current landscape of the biosimilars segment, regulatory considerations given the 2016 guidelines in India and global regulatory precedents and roadmap for Indian industry\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sathguru\u2019s Healthcare Practice Lead moderates Biosimilars Panel at CII Biotech Conclave\" \/>\n<meta property=\"og:description\" content=\"The session discussed current landscape of the biosimilars segment, regulatory considerations given the 2016 guidelines in India and global regulatory precedents and roadmap for Indian industry\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/\" \/>\n<meta property=\"og:site_name\" content=\"Sathguru News\" \/>\n<meta property=\"article:published_time\" content=\"2018-11-27T07:46:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-01T11:43:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sathguru.com\/news\/wp-content\/uploads\/2018\/11\/CII_Sathguru_Biosimilars-.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"6000\" \/>\n\t<meta property=\"og:image:height\" content=\"4000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"sadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@sathgurumc\" \/>\n<meta name=\"twitter:site\" content=\"@sathgurumc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"sadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sathguru\u2019s Healthcare Practice Lead moderates Biosimilars Panel at CII Biotech Conclave","description":"The session discussed current landscape of the biosimilars segment, regulatory considerations given the 2016 guidelines in India and global regulatory precedents and roadmap for Indian industry","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/","og_locale":"en_US","og_type":"article","og_title":"Sathguru\u2019s Healthcare Practice Lead moderates Biosimilars Panel at CII Biotech Conclave","og_description":"The session discussed current landscape of the biosimilars segment, regulatory considerations given the 2016 guidelines in India and global regulatory precedents and roadmap for Indian industry","og_url":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/","og_site_name":"Sathguru News","article_published_time":"2018-11-27T07:46:06+00:00","article_modified_time":"2021-04-01T11:43:35+00:00","og_image":[{"width":6000,"height":4000,"url":"https:\/\/www.sathguru.com\/news\/wp-content\/uploads\/2018\/11\/CII_Sathguru_Biosimilars-.jpg","type":"image\/jpeg"}],"author":"sadmin","twitter_card":"summary_large_image","twitter_creator":"@sathgurumc","twitter_site":"@sathgurumc","twitter_misc":{"Written by":"sadmin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/#article","isPartOf":{"@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/"},"author":{"name":"sadmin","@id":"https:\/\/www.sathguru.com\/news\/#\/schema\/person\/3e1fb591be3f42bc88c681ee61ab007a"},"headline":"Sathguru\u2019s Healthcare Practice Lead moderates Biosimilars Panel at CII Biotech Conclave","datePublished":"2018-11-27T07:46:06+00:00","dateModified":"2021-04-01T11:43:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/"},"wordCount":229,"commentCount":0,"publisher":{"@id":"https:\/\/www.sathguru.com\/news\/#organization"},"image":{"@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sathguru.com\/news\/wp-content\/uploads\/2018\/11\/CII_Sathguru_Biosimilars-.jpg","articleSection":["Featured News","Healthcare"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/","url":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/","name":"Sathguru\u2019s Healthcare Practice Lead moderates Biosimilars Panel at CII Biotech Conclave","isPartOf":{"@id":"https:\/\/www.sathguru.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/#primaryimage"},"image":{"@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sathguru.com\/news\/wp-content\/uploads\/2018\/11\/CII_Sathguru_Biosimilars-.jpg","datePublished":"2018-11-27T07:46:06+00:00","dateModified":"2021-04-01T11:43:35+00:00","description":"The session discussed current landscape of the biosimilars segment, regulatory considerations given the 2016 guidelines in India and global regulatory precedents and roadmap for Indian industry","breadcrumb":{"@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/#primaryimage","url":"https:\/\/www.sathguru.com\/news\/wp-content\/uploads\/2018\/11\/CII_Sathguru_Biosimilars-.jpg","contentUrl":"https:\/\/www.sathguru.com\/news\/wp-content\/uploads\/2018\/11\/CII_Sathguru_Biosimilars-.jpg","width":6000,"height":4000},{"@type":"BreadcrumbList","@id":"https:\/\/www.sathguru.com\/news\/2018\/11\/27\/sathgurus-healthcare-practice-lead-moderates-biosimilars-panel-at-cii-biotech-conclave\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sathguru.com\/news\/"},{"@type":"ListItem","position":2,"name":"Sathguru\u2019s Healthcare Practice Lead moderates Biosimilars Panel at CII Biotech Conclave"}]},{"@type":"WebSite","@id":"https:\/\/www.sathguru.com\/news\/#website","url":"https:\/\/www.sathguru.com\/news\/","name":"Sathguru News","description":"Sathguru News","publisher":{"@id":"https:\/\/www.sathguru.com\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sathguru.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.sathguru.com\/news\/#organization","name":"sathguru Management Consultants","url":"https:\/\/www.sathguru.com\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sathguru.com\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.sathguru.com\/news\/wp-content\/uploads\/2017\/04\/Sathguru-logo.png","contentUrl":"https:\/\/www.sathguru.com\/news\/wp-content\/uploads\/2017\/04\/Sathguru-logo.png","width":180,"height":83,"caption":"sathguru Management Consultants"},"image":{"@id":"https:\/\/www.sathguru.com\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/sathgurumc","https:\/\/www.linkedin.com\/company\/sathguru-management-consultants","https:\/\/www.youtube.com\/user\/SathguruConsultants"]},{"@type":"Person","@id":"https:\/\/www.sathguru.com\/news\/#\/schema\/person\/3e1fb591be3f42bc88c681ee61ab007a","name":"sadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sathguru.com\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/028fee43c618fecdf419f8b5e2b991874271dfa82e49a8fc0ff51997d3c1ee41?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/028fee43c618fecdf419f8b5e2b991874271dfa82e49a8fc0ff51997d3c1ee41?s=96&d=mm&r=g","caption":"sadmin"}}]}},"_links":{"self":[{"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/posts\/1026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/comments?post=1026"}],"version-history":[{"count":6,"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/posts\/1026\/revisions"}],"predecessor-version":[{"id":2080,"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/posts\/1026\/revisions\/2080"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/media\/1031"}],"wp:attachment":[{"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/media?parent=1026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/categories?post=1026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sathguru.com\/news\/wp-json\/wp\/v2\/tags?post=1026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}